Sign in

CIK 0001826457

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Monte Rosa Therapeutics, Inc.

Sign in to watch
Ticker
GLUE
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-949-2643
Business address
321 HARRISON AVENUE, SUITE 900, BOSTON, MA, 02118
Former names
Monte Rosa Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$137
in 1 filing

Net −$137. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Bowen Matthew −$137 Principal Accounting Officer sold <1% of stake
Date Insider Transaction Shares Price Value Owned after
2026-07-06 Townson Sharon Chief Scientific Officer Exercise or conversion 10b5-1 +6,000 $6.14 $37K 73,845
2026-07-06 Townson Sharon Chief Scientific Officer Sale 10b5-1 −5,600 $23.25 $130K 68,245
2026-07-06 Townson Sharon Chief Scientific Officer Sale 10b5-1 −400 $24.13 $10K 67,845
2026-07-06 Townson Sharon Chief Scientific Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −6,000 197,290
2026-06-23 Townson Sharon Chief Scientific Officer Exercise or conversion 10b5-1 +3,000 $6.14 $18K 70,845
2026-06-23 Townson Sharon Chief Scientific Officer Sale 10b5-1 −3,000 $20.00 $60K 67,845
2026-06-23 Townson Sharon Chief Scientific Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −3,000 203,290
2026-06-17 Townson Sharon Chief Scientific Officer Exercise or conversion 10b5-1 +3,000 $6.14 $18K 70,845
2026-06-17 Townson Sharon Chief Scientific Officer Sale 10b5-1 −3,000 $19.00 $57K 67,845
2026-06-17 Townson Sharon Chief Scientific Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −3,000 206,290
2026-05-29 Townson Sharon Chief Scientific Officer Exercise or conversion 10b5-1 +6,000 $6.14 $37K 73,845
2026-05-29 Townson Sharon Chief Scientific Officer Sale 10b5-1 −6,000 $19.87 $119K 67,845
2026-05-29 Townson Sharon Chief Scientific Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −6,000 209,290
2026-01-05 Townson Sharon Chief Scientific Officer Sale −3,155 $15.17 $48K 67,845
2026-01-02 Townson Sharon Chief Scientific Officer Grant or award +35,000 71,000
2026-01-02 Townson Sharon Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +158,000 158,000
2025-01-02 Townson Sharon Chief Scientific Officer Grant or award +36,000 36,000
2025-01-02 Townson Sharon Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +161,000 161,000
2024-06-03 Townson Sharon Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +40,000 40,000
2023-01-03 Townson Sharon Chief Technology Officer Grant or award · Stock Option (Right to Buy) +78,550 78,550

Page 1 of 2 · 21 trades